Stroke occurrence by hypertension treatment status in Ghana and Nigeria: A case-control study.

Africa Hypertension Prevention Risk factors Stroke

Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
17 Mar 2024
Historique:
received: 06 01 2024
revised: 07 02 2024
accepted: 13 03 2024
medline: 23 3 2024
pubmed: 23 3 2024
entrez: 22 3 2024
Statut: aheadofprint

Résumé

Hypertension is preeminent among the vascular risk factors for stroke occurrence. The wide gaps in awareness, detection, treatment, and control rates of hypertension are fueling an epidemic of stroke in sub-Saharan Africa. To quantify the contribution of untreated, treated but uncontrolled, and controlled hypertension to stroke occurrence in Ghana and Nigeria. The Stroke Investigative Research and Educational Network (SIREN) is a case-control study across 16 study sites in Ghana and Nigeria. Cases were acute stroke (n = 3684) with age- and sex-matched stroke-free controls (n = 3684). We evaluated the associations of untreated hypertension, treated but uncontrolled hypertension, and controlled hypertension at BP of <140/90 mmHg with risk of stroke occurrence. We assessed the adjusted odds ratio and population-attributable risk of hypertension treatment control status associated with stroke occurrence. The frequencies of no hypertension, untreated hypertension, treated but uncontrolled hypertension and controlled hypertension among stroke cases were 4.0%, 47.7%, 37.1%, and 9.2% vs 40.7%, 34.9%, 15.9%, and 7.7% respectively among stroke-free controls, p < 0.0001. The aOR and PAR (95% CI) for untreated hypertension were 6.58 (5.15-8.41) and 35.4% (33.4-37.4); treated but uncontrolled hypertension was 9.95 (7.60-13.02) and 35.9% (34.2-37.5); and controlled hypertension 5.37 (3.90-7.41) and 8.5% (7.6-9.5) respectively. Untreated hypertension contributed a PAR of 47.5% to the occurrence of intracerebral hemorrhage vs 29.5% for ischemic stroke. The aOR of untreated hypertension for stroke occurrence was 13.31 (7.64-23.19) for <50 years; 7.14 (4.51-11.31) for 50-64 years; and 3.48 (2.28-5.30) for 65 years or more. The contribution of untreated hypertension and treated but uncontrolled hypertension to stroke occurrence among indigenous Africans is substantial. Implementing targeted interventions that address gaps in hypertension prevention and treatment, involving the local population, healthcare providers, and policymakers, can potentially substantially reduce the escalating burden of strokes in Africa.

Sections du résumé

BACKGROUND BACKGROUND
Hypertension is preeminent among the vascular risk factors for stroke occurrence. The wide gaps in awareness, detection, treatment, and control rates of hypertension are fueling an epidemic of stroke in sub-Saharan Africa.
PURPOSE OBJECTIVE
To quantify the contribution of untreated, treated but uncontrolled, and controlled hypertension to stroke occurrence in Ghana and Nigeria.
METHODS METHODS
The Stroke Investigative Research and Educational Network (SIREN) is a case-control study across 16 study sites in Ghana and Nigeria. Cases were acute stroke (n = 3684) with age- and sex-matched stroke-free controls (n = 3684). We evaluated the associations of untreated hypertension, treated but uncontrolled hypertension, and controlled hypertension at BP of <140/90 mmHg with risk of stroke occurrence. We assessed the adjusted odds ratio and population-attributable risk of hypertension treatment control status associated with stroke occurrence.
RESULTS RESULTS
The frequencies of no hypertension, untreated hypertension, treated but uncontrolled hypertension and controlled hypertension among stroke cases were 4.0%, 47.7%, 37.1%, and 9.2% vs 40.7%, 34.9%, 15.9%, and 7.7% respectively among stroke-free controls, p < 0.0001. The aOR and PAR (95% CI) for untreated hypertension were 6.58 (5.15-8.41) and 35.4% (33.4-37.4); treated but uncontrolled hypertension was 9.95 (7.60-13.02) and 35.9% (34.2-37.5); and controlled hypertension 5.37 (3.90-7.41) and 8.5% (7.6-9.5) respectively. Untreated hypertension contributed a PAR of 47.5% to the occurrence of intracerebral hemorrhage vs 29.5% for ischemic stroke. The aOR of untreated hypertension for stroke occurrence was 13.31 (7.64-23.19) for <50 years; 7.14 (4.51-11.31) for 50-64 years; and 3.48 (2.28-5.30) for 65 years or more.
CONCLUSION CONCLUSIONS
The contribution of untreated hypertension and treated but uncontrolled hypertension to stroke occurrence among indigenous Africans is substantial. Implementing targeted interventions that address gaps in hypertension prevention and treatment, involving the local population, healthcare providers, and policymakers, can potentially substantially reduce the escalating burden of strokes in Africa.

Identifiants

pubmed: 38518449
pii: S0022-510X(24)00103-5
doi: 10.1016/j.jns.2024.122968
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122968

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest We declare no competing interests.

Auteurs

Fred Stephen Sarfo (FS)

Department of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. Electronic address: stephensarfo78@gmail.com.

Osahon Jeffery Asowata (OJ)

Department of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Nigeria.

Onoja Matthew Akpa (OM)

Department of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, Nigeria; Preventive Cardiology Research Unit, Institute of Cardiovascular Diseases, College of Medicine, University of Ibadan, Nigeria.

Joshua Akinyemi (J)

Preventive Cardiology Research Unit, Institute of Cardiovascular Diseases, College of Medicine, University of Ibadan, Nigeria.

Kolawole Wahab (K)

Department of Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria.

Arti Singh (A)

Department of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Albert Akpalu (A)

Department of Medicine, University of Ghana Medical School, Accra, Ghana.

Priscilla Abrafi Opare-Addo (PA)

Department of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Akinkunmi Paul Okekunle (AP)

Department of Food and Nutrition, Seoul National University, Seoul, Republic of Korea.

Godwin Ogbole (G)

Department of Radiology, University of Ibadan, Nigeria.

Adekunle Fakunle (A)

Department of Public Health, Osun State University, Osogbo, Nigeria.

Oladimeji Adebayo (O)

Department of Medicine, University of Ibadan, Nigeria.

Reginald Obiako (R)

Department of Medicine, Ahmadu Bello University, Zaria, Nigeria.

Cynthia Akisanya (C)

Federal Medical Centre, Abeokuta, Nigeria.

Morenkeji Komolafe (M)

Department of Medicine, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria.

Taiwo Olunuga (T)

Federal Medical Centre, Abeokuta, Nigeria.

Innocent I Chukwuonye (II)

Federal Medical Centre Umuahia, Abia state, Nigeria.

Godwin Osaigbovo (G)

Jos University Teaching Hospital Jos, Nigeria.

Paul Olowoyo (P)

Federal Teaching Hospital, Ido-Ekiti Ado-Ekiti, Nigeria.

Phillip B Adebayo (PB)

Aga Khan University Dar es Salaam, Tanzania.

Carolyn Jenkins (C)

Medical University of South Carolina, Charleston, USA.

Abiodun Bello (A)

Department of Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria.

Ruth Laryea (R)

Department of Medicine, University of Ghana Medical School, Accra, Ghana.

Phillip Ibinaye (P)

Department of Medicine, University of Ibadan, Nigeria.

Olatundun Olalusi (O)

Department of Public Health, Osun State University, Osogbo, Nigeria.

Sunday Adeniyi (S)

Department of Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria.

Oyedunni Arulogun (O)

College of Medicine, University of Ibadan, Nigeria.

Okechukwu Ogah (O)

Department of Medicine, University of Ibadan, Nigeria.

Abiodun Adeoye (A)

Department of Medicine, University of Ibadan, Nigeria.

Dialla Samuel (D)

Department of Medicine, University of Ibadan, Nigeria.

Benedit Calys-Tagoe (B)

Department of Medicine, University of Ghana Medical School, Accra, Ghana.

Hemant Tiwari (H)

University of Alabama at Birmingham, Birmingham, AL, USA.

Onyemelukwe Obiageli (O)

Department of Medicine, Ahmadu Bello University, Zaria, Nigeria.

Yaw Mensah (Y)

Korle Bu Teaching Hospital, Accra, Ghana.

Lambert Appiah (L)

Department of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Rufus Akinyemi (R)

Department of Medicine, University of Ibadan, Nigeria; Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria; Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Nigeria.

Bruce Ovbiagele (B)

Weill Institute for Neurosciences, School of Medicine, University of California San-Francisco, USA.

Mayowa Owolabi (M)

Preventive Cardiology Research Unit, Institute of Cardiovascular Diseases, College of Medicine, University of Ibadan, Nigeria; Department of Medicine, University of Ibadan, Nigeria; Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Nigeria; Lebanese American University, Beirut, Lebanon. Electronic address: mayowaowolabi@yahoo.com.

Classifications MeSH